Gland Pharma Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹1,742.79 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.80 per cent from ₹1,695.36 crore. This corresponds to a year-on-year *(YoY) growth of 22.31 per cent.
Operating Profit
Operating Profit stands at ₹513.02 crore, reflecting a quarter-on-quarter *(QoQ) increase of 24.97 per cent from ₹410.53 crore. This corresponds to a year-on-year *(YoY) growth of 47.62 per cent.
PBDT
PBDT stands at ₹614.46 crore, reflecting a quarter-on-quarter *(QoQ) increase of 30.80 per cent from ₹469.78 crore. This corresponds to a year-on-year *(YoY) growth of 59.98 per cent.
Profit Before Tax
Profit Before Tax stands at ₹505.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 39.67 per cent from ₹362.13 crore. This corresponds to a year-on-year *(YoY) growth of 75.42 per cent.
Net Profit
Net Profit stands at ₹366.68 crore, reflecting a quarter-on-quarter *(QoQ) increase of 40.23 per cent from ₹261.48 crore. This represents a 96.57 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Gland Pharma Ltd News
Gland Pharma Ltd Earnings
- YOY
- QOQ
Gland Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Gland Pharma Ltd Research Reports
Gland Pharma Ltd Financial Reports
Gland Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Gland Pharma | -0.50% | -0.26% | 12.92% | 41.85% | 46.70% | 24.95% |
| Ajanta Pharma | 0.61% | 3.95% | 11.62% | 21.49% | 27.82% | 23.31% |
| Anthem Bioscienc | -0.02% | -0.15% | -2.41% | 3.81% | 21.98% | 2.72% |
| Glaxosmi. Pharma | 0.27% | 1.18% | 12.30% | 2.18% | 6.11% | -21.88% |
| J B Chemicals & | -0.49% | 1.63% | 13.14% | 25.62% | 28.64% | 49.93% |
| Emcure Pharma | -0.76% | -0.58% | 3.54% | 9.70% | 16.08% | 31.78% |
| Wockhardt | 1.85% | 2.94% | -1.96% | 38.64% | 32.87% | 3.51% |
Company Info
Company Information
Chairman / Executive Director / MD / CEO : SRINIVAS SADU
Independent Non Exe. Director : UDO JAHANNES VETTER
Independent Non Exe. Director : ESSAJI GOOLAM VAHANVATI
Non-Exec & Non-Independent Dir : Jia Ai (Allen) Zhang
Independent Non Exe. Director : Naina Lal Kidwai
Non-Exec & Non-Independent Dir : Wenjie Zhang
Non-Exec & Non-Independent Dir : Wei Huang
CS / Compliance Officer / Vice President : SAMPATH KUMAR PALLERLAMUDI
Additional Director : William Robert Keller